554 related articles for article (PubMed ID: 15138197)
1. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
2. Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome.
Ishihara K; Amano K; Takaki E; Shimohata A; Sago H; Epstein CJ; Yamakawa K
Cereb Cortex; 2010 May; 20(5):1131-43. PubMed ID: 19710359
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development.
Potier MC; Rivals I; Mercier G; Ettwiller L; Moldrich RX; Laffaire J; Personnaz L; Rossier J; Dauphinot L
J Neurochem; 2006 Apr; 97 Suppl 1():104-9. PubMed ID: 16635258
[TBL] [Abstract][Full Text] [Related]
4. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
Rachidi M; Lopes C
Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
[TBL] [Abstract][Full Text] [Related]
5. Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome.
Siarey RJ; Villar AJ; Epstein CJ; Galdzicki Z
Neuropharmacology; 2005 Jul; 49(1):122-8. PubMed ID: 15992587
[TBL] [Abstract][Full Text] [Related]
6. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.
Belichenko PV; Kleschevnikov AM; Salehi A; Epstein CJ; Mobley WC
J Comp Neurol; 2007 Oct; 504(4):329-45. PubMed ID: 17663443
[TBL] [Abstract][Full Text] [Related]
7. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
Rachidi M; Lopes C
Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
[TBL] [Abstract][Full Text] [Related]
8. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
[TBL] [Abstract][Full Text] [Related]
9. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome.
Sago H; Carlson EJ; Smith DJ; Rubin EM; Crnic LS; Huang TT; Epstein CJ
Pediatr Res; 2000 Nov; 48(5):606-13. PubMed ID: 11044479
[TBL] [Abstract][Full Text] [Related]
10. Down syndrome mouse models are looking up.
Reeves RH
Trends Mol Med; 2006 Jun; 12(6):237-40. PubMed ID: 16677859
[TBL] [Abstract][Full Text] [Related]
11. Towards the understanding of Down syndrome using mouse models.
Yamakawa K
Congenit Anom (Kyoto); 2012 Jun; 52(2):67-71. PubMed ID: 22639990
[TBL] [Abstract][Full Text] [Related]
12. Expression of trisomic proteins in Down syndrome model systems.
Spellman C; Ahmed MM; Dubach D; Gardiner KJ
Gene; 2013 Jan; 512(2):219-25. PubMed ID: 23103828
[TBL] [Abstract][Full Text] [Related]
13. Proliferation deficits and gene expression dysregulation in Down's syndrome (Ts1Cje) neural progenitor cells cultured from neurospheres.
Moldrich RX; Dauphinot L; Laffaire J; Vitalis T; Hérault Y; Beart PM; Rossier J; Vivien D; Gehrig C; Antonarakis SE; Lyle R; Potier MC
J Neurosci Res; 2009 Nov; 87(14):3143-52. PubMed ID: 19472221
[TBL] [Abstract][Full Text] [Related]
14. Down syndrome gene dosage imbalance on cerebellum development.
Moldrich RX; Dauphinot L; Laffaire J; Rossier J; Potier MC
Prog Neurobiol; 2007 Jun; 82(2):87-94. PubMed ID: 17408845
[TBL] [Abstract][Full Text] [Related]
15. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I).
Cheon MS; Kim SH; Yaspo ML; Blasi F; Aoki Y; Melen K; Lubec G
Amino Acids; 2003; 24(1-2):111-7. PubMed ID: 12624742
[TBL] [Abstract][Full Text] [Related]
16. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
Annerén G; Edman B
APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
[TBL] [Abstract][Full Text] [Related]
17. Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities.
Li Z; Yu T; Morishima M; Pao A; LaDuca J; Conroy J; Nowak N; Matsui S; Shiraishi I; Yu YE
Hum Mol Genet; 2007 Jun; 16(11):1359-66. PubMed ID: 17412756
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling in the adult Down syndrome brain.
Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
[TBL] [Abstract][Full Text] [Related]
19. Dynamic changes in gene expression profiles of 22q11 and related orthologous genes during mouse development.
Amati F; Biancolella M; Farcomeni A; Giallonardi S; Bueno S; Minella D; Vecchione L; Chillemi G; Desideri A; Novelli G
Gene; 2007 Apr; 391(1-2):91-102. PubMed ID: 17321697
[TBL] [Abstract][Full Text] [Related]
20. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
Olson LE; Richtsmeier JT; Leszl J; Reeves RH
Science; 2004 Oct; 306(5696):687-90. PubMed ID: 15499018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
